Swiss drug maker is planning to shutter its 1,000-worker Palo Alto research lab as it pursues its takeover bid for Genentech Inc.
After rejecting a $1.4 billion offer from King in August, on Tuesday Alpharma's board adopted a shareholders rights plan to head off a hostile takeover bid.
APP Pharmaceuticals said Tuesday it expects the deal to close by mid-September, now that the Federal Trade Commission has completed its review of the $3.7 billion deal.
Japanese drug maker said it would buy U.S. pharmaceutical company in a bid to expand its business operations in the American market.
Siemens Healthcare Diagnostics, Advance Medical Inc., and Covidien are all planning to expand operations in Massachusetts.
Belgian pharmaceutical company to shed nearly a fifth of its work force as revenues are expected to fall because of the expiration of exclusive patents for older medicines.
Japanese company said Tuesday it has acquired an entire stake in Interpharma Praha, a.s., a Czech drug maker strong in pharmaceutical ingredients and nutrition products.
Drugmaker said its unsolicited buyout bid for Alpharma is part of a move to create a large diverse specialty pharmaceutical company and expand its pain therapy products.
Employee retention plan announced along with Genentech's rejection of Roche's buyout offer will cost the biotechnology giant about $371 million.
Agricultural chemical company agreed to sell its Posilac brand of cow hormones to drug maker Eli Lilly & Co.'s Elanco animal health unit.
Layoffs and restructurings are taking a toll on drug and medical technology companies in New Jersey, one of the state's most important industries.
All but one of the five manufacturers expected to supply a record 143 million doses to the U.S. began shipping the vaccine in the past two weeks, several weeks earlier than usual.
Biotechnology giant rejects a buyout offer from its majority owner Roche, saying the $43.7 billion takeover bid undervalues the company.
Company could possibly sell its specialty pharmaceuticals unit as it moves forward with a spinoff of its biotechnology division.
Despite calling the $4.5 billion buyout offer too low, ImClone said its board formed a committee to weigh the offer from cancer drug partner Bristol-Myers Squibb.
Drug developer offered $4.5 billion in cash for its cancer drug partner Thursday, though the biotechnology company's board has yet to comment on the proposal.
Government agencies have seized more than $24 million worth of unapproved new drugs from St. Louis-based KV Pharmaceutical Co.
Shortage of qualified workers, limited access to capital and lack of space hinder the state’s bioscience industry, but organizing efforts are helping address the challenges holding it back.
Deal would add Acambis' key smallpox vaccine ACAM2000 to the existing portfolio of Sanofi Pasteur, the vaccines business of Sanofi-Aventis.
Company has officially formed a special committee consisting of its three independent board members to consider Roche Holding's takeover bid.
Lawsuit claims the Swiss pharmaceutical company is offering too little in its takeover bid for Genentech Inc.
Pharmaceutical giant plans to buy Arius Research Inc. for $190.4 million as the latest in a series of purchases of North American biotechnology companies.
Israeli generic drug maker completed a $360 million acquisition of Bentley Pharmaceuticals, which will expand its operations in Spain.
Pharmaceutical company Roche Holding will buy U.S. gene therapy company Mirus Bio Corp. for $125 million.